Key facts
- Natera and CytoDyn have entered into a partnership.
- The collaboration focuses on cancer treatment research.
- Natera will contribute its expertise in genetic testing.
- CytoDyn will contribute its focus on novel therapeutic approaches.
Natera, a leader in genetic diagnostics, has announced a strategic partnership with CytoDyn, a biotechnology company focused on developing novel therapies. This collaboration is set to advance research and development efforts in the field of cancer treatment. The partnership will combine Natera's advanced capabilities in genetic testing and analysis with CytoDyn's innovative approach to therapeutic development. Both companies aim to accelerate the discovery and potential application of new cancer treatments through this joint initiative.